Köpek Lenfomalarında Ki-67, Bcl-2 ve Bax Ekspresyonunun Histopatoloji, İmmunofenotip ve Prognozla İlişkisi


Egeden E., Yıldırım F.

XI. NATIONAL / II. INTERNATIONAL CONGRESS OF VETERINARY PATHOLOGY, Erzurum, Türkiye, 4 - 08 Eylül 2023, ss.14-15, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Erzurum
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.14-15
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

The remarkable increase in lymphomas, which is expressed as the most common hematopoietic

neoplasm in dogs and is among the three most common neoplasm types in the world, and the

development of treatment options have made lymphomas an important issue in veterinary

oncology. In the study, the immunophenotype of canine lymphomas was determined with the

help of CD3, CD4, CD79α and Pax5 antibodies, and the tumors were classified into

cytomorphological and histological subtypes according to the updated Kiel and Revised

European-American Lymphoma Classification (REAL) systems. It was aimed to reveal the

relationship of these classifications with the expression levels of Bcl-2 and Bax, which are

important proteins in the regulation of apoptosis, and prognostic factors such as Ki-67 index

and survival time. In the retrospective study, 45 nodal, splenic and cutaneous lymphoma cases

were immunohistochemically labelled with CD3, CD4, CD79α, Pax5, Bcl-2, Bax and Ki-67

antibodies. Histological subclassifications of the cases whose immunophenotypes were

determined according to the revised REAL and updated Kiel systems were performed. Survival

times were recorded. Statistical analysis of the obtained data was done with Jamovi software,

version 2.3.21. In the study, Ki-67 proliferation marker was significantly higher as an indicator

that could be interpreted as a more aggressive course of especially nodal lymphomas in male

dogs (P=0.002); dogs with nodal lymphoma had significantly shorter survival times than splenic

and cutaneous cases (P=0.005); Pax 5 antibody is a strong (P<0.001) marker for detecting B

lymphomas; It has been concluded that the Kiel classification is a better system than the REAL

system in determining prognosis, and finally, the REAL system is useful. Still, the immune

panel should be broadened to identify subtypes.